In this study, we demonstrated that Erdr1 acts as an apoptosis-stimulating factor for melanoma via the downregulation of Bcl-2 and upregulation of Bax, ultimately leading to increased apoptosis in melanoma cells both in vitro and in vivo. Here, BCL2 is linked to melanoma.